Wortmannin inhibits IGF-dependent differentiation in the mouse myogenic cell line C2

Comptes Rendus de l'Academie des Sciences - Serie III

Volumn 320, Issue 5, 1997, Pages 367-374

  Pinset, Christian ^a   Garcia, Alphonse ^a   Rousse, Sophie ^b   Dubois, Catherine ^b   Montarras, Didier ^a  

^a CNRS   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

C2 myoblasts; IGFs; Myogenesis; Myogenin; PI 3 kinase

Indexed keywords

COMPLEMENTARY RNA; MITOGEN ACTIVATED PROTEIN KINASE; MYOD PROTEIN; MYOGENIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE INHIBITOR; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C RECEPTOR; WORTMANNIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0030868467     PISSN: 07644469     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0764-4469(97)85024-X     Document Type: Article

References (39)

1. Florini J.R., Ewton D.Z., Magri K.A. Hormones, growth factors, and myogenic differentiation. Annu. Rev. Physiol. 53:1991;201-216.
2. Lee J.E., Pintar J., Efstratiadis A. Pattern of the insulin-like growth factor II gene expression during early mouse embryogenesis. Development. 110:1990;151-159.
3. Streck R.D., Wood T.L., Hsu M-S., Pintar J.E. Insulin-like growth factor I and II and insulin-like growth factor binding protein-2 RNAs are expressed in adjacent tissues within rat embryonic and fetal limbs. Dev. Biol. 151:1992;586-596.
4. Levinovitz A., Jennische E., Oldfors A., Edwall D., Norstedt G. Activation of insulin-like growth factor II expression during skeletal muscle regeneration in the rat: correlation with myotube formation. Mol. Endocrinol. 6:1992;1227-1234.
5. Tollefsen S.E., Sadow J.L., Rotwein P. Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation. Proc. Natl. Acad. Sci., USA. 86:1989;1543-1547.
6. Tollefsen S.E., Lajara R., McCuster R.H., Clemmons D.R., Rotwein P. Insulin-like growth factor (IGF) in muscle development. J. Biol. Chem. 264:1989;13810-13817.
7. Florini J.R., Magri K.A., Ewton D.Z., James P.L., Grindstaff K., Rotwein P.S. 'Spontaneous' differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J. Biol. Chem. 266:1991;15917-15923.
8. Montarras D., Auradé F., Johnson T., Ilan J., Gros F., Pinset C. Autonomous differentiation in the mouse myogenic cell line, C2, involves a mutual positive control between insulin-like growth factor II and MyoD, operating as early as the myoblast stage. J. Cell Sci. 109:1996;551-560.
9. Cohick W.S., Clemmons D.R. The insulin-like growth factors. Annu. Rev. Physiol. 55:1993;131-153.
10. Myers M.G. Jr., Sun X.J., White M.F. The IRS-1 signaling system. Trends Biochem. Sci. 19:1994;289-293.
11. Maruta H., Burgess A.W. Regulation of the Ras signalling network. Bioessays. 16:1994;489-496.
12. Kapeller R., Cantley L.C. Phosphatidylinositol 3-kinase. BioEssays. 16:1994;565-576.
13. Kotani K., Yonezawa K., Hara K., Ueda H., Kitamura Y., Sakaue H., Ando A., Chavanieu A., Calas B., Grigorescu F., Nishiyama M., Waterfield M., Kasuga M. Involvement of phosphoinositide 3-kinase in insulin- or IGF-1-induced membrane ruffling. EMBO J. 13:1994;2313-2321.
14. 3. J. Biol. Chem. 269:1994;32358-32367.
15. Nakanishi S., Kakita S., Takahashi I., Kawahara K., Tsukuda E., Sano T., Yamada K., Yoshida M., Kase H., Matsuda Y., Hashimoto Y., Nonomura Y. Wortmannin, a microbial product inhibitor of myosin light chain kinase. J. Biol. Chem. 267:1992;2157-2163.
16. Dudley D.T., Pang L., Decker S.J., Bridges A.J., Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci., USA. 92:1995;7686-7689.
17. Rebollo A., Mérida I., Gomez J., Pitton C., Silva A., Martinez C., Garcia A. Differential effect of rapamycin and cyclosporin A in proliferation in a murine T cell line expressing either intermediate or high affinity receptor for IL-2. Cytokine. 7:1995;277-286.
18. Pinset C., Montarras D., Chenevert J., Minty A., Barton P., Laurent C., Gros F. Control of myogenesis in the mouse myogenic C2 cell line by medium composition and by insulin: characterization of permissive and inducible C2 myoblasts. Differentiation. 38:1988;28-34.
19. Froeschlé A., Carnac G., Alric S., Montarras D., Pinset C., Rochette-Egly C., Bonnieu A. RXRα is essential for mediating the all-trans retinoic acid-induced growth arrest of C2 myogenic cells. Oncogene. 12:1996;411-421.
20. Kimura K., Hattori S., Kabuyama Y., Shizawa Y., Takayanagi J., Nakamura S., Toki S., Matsuda Y., Onodera K., Fukui Y. Neurite outgrowth of PC12 cells is suppressed by a Wortmannin, a specific inhibitor of the phosphatidylinositol 3-kinase. J. Biol. Chem. 269:1994;18961-18967.
21. Wright W.E., Sassoon D.A., Lin V.K. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell. 56:1989;607-617.
22. Kaliman P., Vinals F., Testar X., Palacin M., Zorzano A. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J. Biol. Chem. 271:1996;19146-19151.
23. Powis G., Bonjouklian R., Berggren M.M., Gallegos A., Abraham R., Ashendel C., Zalkow L., Matter W.F., Dodge J., Grindey G., Vlahos C.J. Wortmannin, a potent and a selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res. 54:1994;2419-2423.
24. Hunter T. When is a lipid kinase not a lipid kinase? When it is a protein kinase. Cell. 83:1995;1-4.
25. Stephens L., Smrcka A., Cooke F.T., Jackson T.R., Sternweis P.C., Hawkins P.T. A novel phosphoinositide 3 kinase activity in myeloid-derived cells is activated by G protein βγ subunits. Cell. 77:1994;83-93.
26. Volinia S., Dhand R., Vanhaesebroeck B., MacDougall L.K., Stein R., Zvelebil M.J., Domin J., Panaretou C., Waterfield M.D. A human phosphatidylinositol 3-kinase complex related to the yeast Vps34p-Vsp15p protein sorting system. EMBO J. 14:1995;3339-3348.
27. Hartley K.O., Gell D., Smith G.C.M., Zhang H., Divecha N., Connelly M.A., Admon A., Lees-Miller S.P., Anderson C.W., Jackson S.P. DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell. 82:1995;849-856.
28. Sheptner H., Joly M., Hartley D., Corvera S. Potential sites of PI-3 kinase function in the endocytic pathway revealed by the PI-3 kinase inhibitor, Wortmannin. J. Cell Biol. 132:1996;595-605.
29. Shepherd P.R., Soos M.A., Siddle K. Inhibitors of phosphoinositide 3-kinase block exocytosis but not endocytosis of transferrin receptors in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 211:1995;535-539.
30. Chung J., Grammer T.C., Lemon K.P., Kazlauskas A., Blenis J. PDGF- and insulin-dependent pp70s6k activation is mediated by phosphatidylinositol-3-OH kinase. Nature. 370:1994;71-75.
31. Franke T.F., Yang S-I., Chan T.O., Datta K., Kazlauskas A., Morrison D.K., Kaplan D.R., Tsichlis P.N. The protein kinase encoded by the AKT proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 81:1995;727-736.
32. Gossett L.A., Zhang W., Olson E.N. Dexamethasone-dependent inhibition of differentiation of C2 myoblasts bearing steroid-inducible N-ras oncogenes. J. Cell Biol. 106:1988;2127-2137.
33. Pang L., Sawada T., Decker S.T., Saltiel A.R. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270:1995;13585-13588.
34. Noda M., Ko M., Ogura A., Liu D-G., Amano T., Takano T., Ikawa Y. Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line. Nature. 318:1985;73-75.
35. Bar-Sagi D., Feramisco J.R. Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation. Cell. 42:1985;841-848.
36. Tomiyama K., Nakata H., Sasa H., Arimura S., Nishio E., Watanabe Y. Wortmannin, a specific phosphatidylinositol 3-kinase inhibitor, inhibits adipocytic differentiation of 3T3-L1 cells Biochem. Biophys. Res. Commun. 212:1995;263-269.
37. Benito M., Porras A., Nebreda A.R., Santos E. Differentiation of 3T3-L1 fibroblasts to adipocytes induced by transfection of ras oncogenes. Science. 253:1991;565-568.
38. Pinset C., Whalen R.G. Induction of myogenic differentiation in serum-free medium does not require DNA synthesis. Develop. Biol. 108:1985;284-289.
39. Lassar A.B., Skapek S.X., Novitch B. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol. 6:1994;788-794.